WELLINGTON, Fla., Jan. 16, 2008 (PRIME NEWSWIRE) -- Ken Weiner, publisher of Shazamstocks.com, today announced profile coverage of Millennium Biotechnologies Group, Inc. (OTCBB:MBTG).The Profile is a comprehensive look at the company's growth initiative. You can view the complete profile at http://www.shazamstocks.com/profiles/mbtg/index.php.
About SURGEX(tm):
SURGEX(tm) (www.surgexsports.com) was created from Millennium's extensive experience providing advanced nutritional formulas to some of the most prestigious medical institutions throughout the United States. The proprietary SURGEX(tm) formula intends to meet the growing demand of elite level professional and amateur athletes and their coaches looking for nutritional support in a marketplace dominated by products with no clinical proof of benefit, unsubstantiated claims, excess protein, stimulants, and banned substances.
In double blind placebo controlled trials at the Rutgers University Human Performance Lab SURGEX(tm) significantly outperformed leading competitive products by assisting in reducing the damaging effects of exercise by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). The formula meets NCAA guidelines for use by collegiate athletes and is certified by The Banned Substances Control Group (BSCG) to contain no banned substances.
About Millennium:
Millennium's three proprietary, marketed products, which form the Company's Resurgex(r) Continuum of Care, include Resurgex Select(r), Resurgex(r), and Resurgex Plus(r). Resurgex Select(r) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(r) and Resurgex Plus(r) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium is also recently developed a SURGEX(TM) sports nutrition formula, clinically proven to address the nutritional concerns of both professional and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function.
About Shazamstocks.com
Shazamstocks.com is a Shazamstocks Inc. Company. Shazamstocks.com is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. Shazamstocks Inc. is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. Shazamstocks.com's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. Shazamstocks.com provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. Stock alert offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.shazamstocks.com. We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Ken Weiner at 561-793-2665, or via email at editor@shazamstocks.com
Disclosure: Shazamstocks.com has been compensated by a third party. All Penny stocks, sixteen thousand dollars for publication of this profile.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking information. Statements that are not descriptions of historical facts are forward-looking statements provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. These statements are made to enable a better understanding of our business, but because these forward-looking statements are subject to many risks, uncertainties, future developments and changes over time, actual results may differ materially from those expressed or implied by such forward-looking statements. Examples of forward-looking statements are statements about anticipated financial or operating results, financial projections, business prospects, future product performance and other matters that are not historical facts. Such statements often include words such as "believes," "expects," "anticipates," "intends," "plans," "estimates" or similar expressions.
These forward-looking statements are based on the information that was currently available to us, and the expectations and assumptions that were deemed reasonable by us, at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law, and all such forward-looking statements should be read as of the time the statements were made, and with the recognition that these forward-looking statements may not be complete or accurate at a later date.